Literature DB >> 16952843

Molecular biology in acute leukemia.

Mireia Camós1, Dolors Colomer.   

Abstract

Acute leukemia is a clonal expansion of tumoral cells in bone marrow, blood or other tissues. The acute leukemias are classified as myeloid or lymphoid based on the lineage of the blast cells. Over the past three decades, remarkable advances have been made in the classification and treatment of acute leukemias. In the last years, the research into the molecular pathogenesis of acute leukemia has progressed. The knowledge of chromosomal translocations breakpoints and possible candidate oncogenes and tumor suppressor genes has allowed the integration of all these events into multistep cascades that impact specific signal transduction pathways and lead to leukemic transformation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952843     DOI: 10.1007/s12094-006-0060-6

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  71 in total

1.  Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.

Authors:  Scott A Armstrong; Andrew L Kung; Meghann E Mabon; Lewis B Silverman; Ronald W Stam; Monique L Den Boer; Rob Pieters; John H Kersey; Stephen E Sallan; Jonathan A Fletcher; Todd R Golub; James D Griffin; Stanley J Korsmeyer
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

2.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

3.  CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.

Authors:  Vahid Asnafi; Isabelle Radford-Weiss; Nicole Dastugue; Chantal Bayle; Daniel Leboeuf; Christiane Charrin; Richard Garand; Marina Lafage-Pochitaloff; Eric Delabesse; Agnes Buzyn; Xavier Troussard; Elizabeth Macintyre
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

4.  Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.

Authors:  J Liang; L Prouty; B J Williams; M A Dayton; K L Blanchard
Journal:  Blood       Date:  1998-09-15       Impact factor: 22.113

5.  Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants.

Authors:  N Satake; N Maseki; M Nishiyama; H Kobayashi; M Sakurai; H Inaba; N Katano; Y Horikoshi; H Eguchi; M Miyake; M Seto; Y Kaneko
Journal:  Leukemia       Date:  1999-07       Impact factor: 11.528

6.  Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

Authors:  Christian Thiede; Sina Koch; Eva Creutzig; Christine Steudel; Thomas Illmer; Markus Schaich; Gerhard Ehninger
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

Review 7.  Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.

Authors:  Clemens Grabher; Harald von Boehmer; A Thomas Look
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

Review 8.  In vivo analysis of the molecular genetics of acute promyelocytic leukemia.

Authors:  P P Pandolfi
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

9.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

10.  The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain.

Authors:  Kristie L Durst; Bart Lutterbach; Tanawan Kummalue; Alan D Friedman; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

View more
  3 in total

Review 1.  Gene expression regulation and cancer.

Authors:  M Dolore Delgado; Javier León
Journal:  Clin Transl Oncol       Date:  2006-11       Impact factor: 3.405

2.  Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line: implications for CD4 regulation.

Authors:  Katie L Kathrein; Sheila Chari; Susan Winandy
Journal:  J Biol Chem       Date:  2008-02-20       Impact factor: 5.157

3.  Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol.

Authors:  Eddy Supriyadi; Anjo J P Veerman; Ignatius Purwanto; Peter M Vd Ven; Jacqueline Cloos
Journal:  J Oncol       Date:  2012-11-26       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.